New review to read! Perioperative immune checkpoint inhibitor therapy across tumors.

➡️ Insights and shared lessons from a rapidly evolving field.
➡️ Major evolution in curative-intent oncology.

🔗 doi.org/10.1111/joim.70073

#adjuvanttherapy #immunecheckpointinhibitors #neoplasms

STAT5-activating oncogenes-induced oncostatin M (OSM) expression promotes #ImmuneEvasion and disease progression, establishing OSM signaling as a promising #TherapeuticTarget for myeloproliferative #Neoplasms.

#STTT #OpenAccess: doi.org/10.1038/s413...

January Issue: The Impact of Preoperative Colonoscopy for #Appendiceal Mucinous #Neoplasms

https://rdcu.be/eX2Fq

Risk and Outcomes of Second Malignancies in Patients With Philadelphia Chromosome–Negative Myeloproliferative Neoplasm: A SEER Database Analysis | JCO Oncology Practice PURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), have an increased incidence of second malig...

Pacientes c/neoplasias mieloproliferativas tienen mayor riesgo de segundas neoplasias que la población general, lo cual se asocia con una menor supervivencia, por lo que se necesitan pesquisas de cáncer, exámenes dermatológicos y vigilancia a largo plazo #Neoplasms #MPN ascopubs.org/doi/abs/10.1...

For patients with myeloid/lymphoid #neoplasms with FGFR1 rearrangements, #pemigatinib led to high rates of complete clinical and cytogenetic responses in chronic-phase disease, at 96% and 88%, respectively, with encouraging activity in blast-phase disease: https://ow.ly/UKCT50XKhvX
#HemeSky #OncSky

The December issue is available now! Check out the link below to read articles on #isatuximab for R/R AL #amyloidosis, ATRA-ATO combination therapy for APL, #pemigatinib for myeloid & lymphoid #neoplasms with FGFR1 rearrangements, and more: https://ow.ly/fzzm50XARLQ

See what's to come in the December issue of ASH Clinical News! Highlights of next month's issue include articles on the past, present, and future of #hematology, rethinking the classification of #myeloid #neoplasms, early treatment in #MCL, and more: https://ow.ly/ngmg50XxL5o
#HemeSky

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey The introduction of poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer has raised increasing concerns about PARPi-related myeloid neopl…

PARPi and #myeloid #neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]

Test Bank For NR 283 Chapter 20: Neoplasms and Cancer
#testbank #testbankfornr283 #nr283 #nursing #chapter20 #cancer #Neoplasms

www.stuvia.com/doc/9082044/...

Risk of SMN Low After CAR-T Therapy: The risk of secondary #myeloid #neoplasms (SMNs) following #CD19 #CARTcell therapy may be lower than expected. According to a retrospective study, SMNs occurred in 2.5% of patients after treatment with CAR T-cell therapy.
#HemeSky

Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated - OncoDaily Learn about neoplasms, including benign and malignant tumors, genetic mutations, BRCA-related cancer risks, and how abnormal cell growth leads to cancer.

Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Neoplasms #Benign #Malignant

a 🇫🇮 study showed that patients with hidradenitis suppurativa experience a substantially reduced life expectancy of around 15 years due to sequelae of concomitant disorders ( ischaemic #heartdiseases, #cerebrovascular diseases, #neoplasms.

Ignacio Ruz-Caracuel et al. summarise current knowledge of cancer stem cells (CSCs) in #neuroendocrine #neoplasms and highlight the importance of understanding the role of CSCs in the biology of these rare tumors. Read it here 👉 https://buff.ly/40k6Tle

Plasma Cell #Neoplasms with Spreading in the #Blood and Tissues: Extramedullary #Myeloma Disease, a Rare Aggressive Form of Multiple #Myeloma | doi.org/10.4084/MJHI... | #Cansky #Oncsky #MedSky #openaccess #hematology 🩸🧪👨‍🎓😷